Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

98
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
98

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data and Dogma in Hepatocellular Carcinoma.

International journal of radiation oncology, biology, physics·2026
Same author

Best Practices for Treatment Team Collaboration in the Use of Radiopharmaceutical Therapy in the United States.

JCO oncology practice·2026
Same author

Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic Cancer.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Multi-Center Randomized Trial Evaluating the Safety and Effectiveness of the Instylla Hydrogel Embolic System (HES) for Vascular Occlusion of Hypervascular Tumors.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Diffusion of the alpha-particle emitting daughters of alpha-DaRT sources in an orthotopic murine model of colorectal adenocarcinoma.

Scientific reports·2026
Same author

Retrospective patient-specific intravascular brachytherapy dosimetry using optical coherence tomography imaging.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026

Related Experiment Video

Updated: Jul 13, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

487

AAPM Medical Physics Practice Guideline 14.a: Yttrium-90 microsphere radioembolization.

Nathan C Busse1, Muthana S A L Al-Ghazi2, Nadine Abi-Jaoudeh3

  • 1Colorado Associates in Medical Physics, Denver, Colorado, USA.

Journal of Applied Clinical Medical Physics
|October 11, 2023
PubMed
Summary

This study outlines essential guidelines for establishing Yttrium-90 (90 Y) radioembolization programs. It details medical physicist roles, patient preparation, dose delivery, and safety protocols for treating liver tumors.

Keywords:
MPPGYttrium-90brachytherapyhepatic tumorspractice guidelineradioembolization

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K

Related Experiment Videos

Last Updated: Jul 13, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

487
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K

Area of Science:

  • Interventional Radiology
  • Medical Physics
  • Nuclear Medicine

Background:

  • Radioembolization with Yttrium-90 (90 Y) microspheres is a standard treatment for liver tumors.
  • Establishing a safe and effective 90 Y program requires comprehensive guidelines.
  • Medical physicists are crucial for ensuring patient and staff safety.

Purpose of the Study:

  • To provide minimum practice guidelines for establishing and supporting Yttrium-90 (90 Y) radioembolization programs.
  • To identify key roles, procedures, and safety considerations for program implementation.
  • To guide institutions in regulatory compliance and staff training.

Main Methods:

  • Summarizing available Yttrium-90 (90 Y) products and suppliers.
  • Describing pre-treatment patient workup, including imaging (Technetium-99m (Tc-99m) mapping, MRI/CT/PET-CT) and dose calculation.
  • Detailing the treatment procedure, dose assay, image guidance, radiation safety measures, and post-procedure surveys.

Main Results:

  • Identification of critical steps from patient selection to post-treatment assessment.
  • Emphasis on the importance of accurate lung shunt fraction (LSF) quantification and tumor burden assessment.
  • Highlighting the necessity of institutional radioactive materials license amendments and comprehensive staff training.

Conclusions:

  • Successful implementation of Yttrium-90 (90 Y) radioembolization necessitates adherence to detailed guidelines.
  • Robust safety protocols, regulatory compliance, and thorough training are paramount.
  • These guidelines aim to ensure the safe and effective delivery of Yttrium-90 (90 Y) therapy for liver malignancies.